What does ChatGPT mean for Healthcare? OpenAI ChatGPT AI healthcare technology
What can ChatGPT do, and why is it so popular?References and Further Reading
ChatGPT exists in the form of an AI-enabled chatbot that mirrors intuitive human conversation. It can write articles, essays, job applications, and even jokes and poetry in response to text prompts. Since it was introduced to the world in November 2022, Chat GPT has wowed the world with its capabilities, having passed law exams at the University of Minnesota and the University of Pennsylvania's Wharton School of Business, written feature-length articles, and coded full websites.
How might ChatGPT revolutionize healthcare? There are many potential applications of ChatGPT in healthcare, and the extent to which ChatGPT might improve healthcare may cause a profound shift in our healthcare systems. Medical record keeping is another area where ChatGPT will likely improve healthcare systems. Here, it could summarize patient medical histories, effectively streamlining the record-keeping process. Theoretically, healthcare professionals could dictate to ChatGPT, which could automatically summarize the key details.
Drug Discovery eBook Compilation of the top interviews, articles, and news in the last year. Download a free copy Already, there are many online tools designed to check symptoms to help patients determine when medical attention is required. ChatGPT can be used to develop more accurate and reliable symptom checkers that could provide more fine-tuned guidance on the next steps.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
OpenAI rolls out ChatGPT plugins for third partiesICYMI... Amid worries over safety and that privacy leak, OpenAI rolls out ChatGPT plugins for third parties
Read more »
5 ways that ChatGPT is better than Google Bard (and 3 ways it isn't)We've grilled the AI chatbots and teased out their differences.
Read more »
Is nirmatrelvir treatment of SARS-CoV-2 associated with a lower risk of post–COVID-19 condition?Is nirmatrelvir treatment of SARS-CoV-2 associated with a lower risk of post–COVID-19 condition? JAMAInternalMed WUSTLmed STLOUISVA SARSCoV2 covid COVID19 coronavirus longcovid disease infection immunology
Read more »
Dark and Darker developer uses ChatGPT AI tool in bid to prove it hasn't infringed copyrightIronmace, the developer behind upcoming looter Dark and Darker, has used ChatGPT to try and prove it hasn't infringed any copyright claims.
Read more »
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications - Molecular NeurodegenerationAs the leading cause of dementia, Alzheimer's disease (AD) is a major burden on affected individuals, their families and caregivers, and healthcare systems. Although AD can be identified and diagnosed by cerebrospinal fluid or neuroimaging biomarkers that concord with neuropathological evidence and clinical symptoms, challenges regarding practicality and accessibility hinder their widespread availability and implementation. Consequently, many people with suspected cognitive impairment due to AD do not receive a biomarker-supported diagnosis. Blood biomarkers have the capacity to help expand access to AD diagnostics worldwide. One such promising biomarker is plasma phosphorylated tau (p-tau), which has demonstrated specificity to AD versus non-AD neurodegenerative diseases, and will be extremely important to inform on clinical diagnosis and eligibility for therapies that have recently been approved. This review provides an update on the diagnostic and prognostic performances of plasma p-tau181, p-tau217 and p-tau231, and their associations with in vivo and autopsy-verified diagnosis and pathological hallmarks. Additionally, we discuss potential applications and unanswered questions of plasma p-tau for therapeutic trials, given their recent addition to the biomarker toolbox for participant screening, recruitment and during-trial monitoring. Outstanding questions include assay standardization, threshold generation and biomarker verification in diverse cohorts reflective of the wider community attending memory clinics and included in clinical trials.
Read more »
5 ways that ChatGPT is better than Google Bard (and 3 ways it isn't)We've grilled the AI chatbots and teased out their differences.
Read more »